Nov 4 (Reuters) - Assembly Biosciences Inc ASMB.O :
* ASSEMBLY BIOSCIENCES REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND RECENT HIGHLIGHTS
* Q3 LOSS PER SHARE $0.41
* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE
$190.1
MILLION AS OF SEPTEMBER 30, 2021
* CASH POSITION IS PROJECTED TO FUND OPERATIONS INTO SECOND
HALF
OF 2023
* Q3 EARNINGS PER SHARE VIEW $-0.56 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX5mTv8K
Further company coverage: ASMB.O
((Reuters.Briefs@thomsonreuters.com;))